Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 80 for cardiovascular medicine

  • Results filtered:
  • Locations: Rochester, MN
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Improve Cardiovascular Health Among African Americans within Faith Communities

    Rochester, MN

  2. Molecular Analysis of Blood for the Detection of Cardiovascular Pathogens

    Rochester, MN

  3. Treating Breast Cancer Patients Undergoing Trastuzumab Treatment with Carvedilol to Reduce Incidence of Heart Failure

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study of the Mayo Clinic College of Medicine Ultrasound System

    Rochester, MN

  5. A Study to Evaluate Wellness Coaching for Caregivers of Thoracic Transplant Candidates

    Rochester, MN

  6. A Study to Evaluate the Safety of Intracoronary Infusion of Extracellular Vesicles in Patients with Acute Myocardial Infarction

    Rochester, MN

  7. Rivet PVS Therapy in Group 2C

    Rochester, MN

  8. Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

    Rochester, MN

  9. Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)

    Rochester, MN

  10. Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)

    Rochester, MN

.

Mayo Clinic Footer